Screener
Perspective Therapeutics CATX Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$26.79M-24.7% | -$26.19M-44.1% | -$37.49M+6.7% | -$25.97M-71.7% | -$21.49M-83.6% | ||
| $1.14M+55.7% | $1.13M+53.8% | $1.01M+42.6% | $775K+15.8% | $733K+28.1% | ||
| $3.05M+26.8% | $2.55M+21.7% | $2.31M+12.1% | $2.16M+10.5% | $2.4M+234% | ||
| -$20.65M-3.5% | -$31.47M-45.8% | -$24.66M+7.3% | -$16.29M-584% | -$19.95M-124% | ||
| $14.2M+1,284% | $6.86M+47.3% | $5.08M-65.3% | $1.99M-93.3% | $1.03M+1.1% | ||
| —— | -$109.55M-1,869% | $28.54M+121% | $13.99M+147% | $4.26M+229% | ||
| $13K0.0% | $15K+15.4% | $13K+8.3% | $13K-18.8% | $13K+62.5% | ||
| $147K+11.4% | $164.36M+1,548% | $0-100% | $213K-66.1% | $132K-99.9% | ||
| —— | $23.34M+236% | —— | -$2.09M— | -$15.56M-114% | ||
| -$34.85M-66.1% | -$38.33M-46.1% | -$29.73M+27.9% | -$18.28M+30.6% | -$20.98M-112% |
FAQ
- How much cash does Perspective Therapeutics generate?
- Perspective Therapeutics (CATX) generated -$93.1M in operating cash flow over the trailing twelve months.
- What is Perspective Therapeutics's free cash flow?
- After $28.1M of capital expenditures, Perspective Therapeutics's free cash flow was -$121.2M over the trailing twelve months, down 5.6% year over year.
- Where does Perspective Therapeutics's cash flow data come from?
- Every line is extracted from Perspective Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.